HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Santiago Pérez-Hoyos Selected Research

efavirenz (Sustiva)

10/2016Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individuals.
8/2012The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Santiago Pérez-Hoyos Research Topics

Disease

14Acquired Immunodeficiency Syndrome (AIDS)
12/2016 - 10/2002
5Infections
08/2015 - 10/2002
4HIV Seropositivity
12/2011 - 10/2002
3COVID-19
10/2022 - 01/2021
3Tuberculosis (Tuberculoses)
05/2012 - 04/2003
2Substance-Related Disorders (Drug Abuse)
03/2014 - 01/2012
2Disease Progression
12/2011 - 05/2010
1Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2022
1Lymphedema (Milroy Disease)
08/2022
1Insulin Resistance
04/2021
1Acromegaly
04/2021
1Multiple Sclerosis
11/2020
1Major Depressive Disorder (Major Depressive Disorders)
01/2018
1Hypoxia (Hypoxemia)
03/2014
1Diarrhea
03/2013
1Liver Diseases (Liver Disease)
04/2006
1HIV Infections (HIV Infection)
01/2006
1Hepatitis C
01/2006
1Coinfection
02/2004
1Human Influenza (Influenza)
11/2003
1Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
04/2003
1Chronic Obstructive Pulmonary Disease (COPD)
01/2002

Drug/Important Bio-Agent (IBA)

3Pharmaceutical PreparationsIBA
01/2021 - 02/2012
2tocilizumab (atlizumab)FDA Link
10/2022 - 06/2022
2efavirenz (Sustiva)FDA Link
10/2016 - 08/2012
2Atazanavir Sulfate (Reyataz)FDA Link
10/2016 - 04/2015
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
04/2021
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2021
1EscitalopramFDA Link
01/2018
1Sertraline (Zoloft)FDA LinkGeneric
01/2018
1Viral RNAIBA
08/2015
1LopinavirFDA Link
04/2015
1AntioxidantsIBA
03/2014
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
03/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2014
1Cholera VaccinesFDA Link
03/2013
1NucleosidesIBA
08/2012
1Nevirapine (Viramune)FDA Link
08/2012
1Reverse Transcriptase InhibitorsIBA
08/2012
1RNA (Ribonucleic Acid)IBA
05/2012
1BilirubinIBA
01/2012
1Serum AlbuminIBA
01/2012
1Illicit Drugs (Recreational Drugs)IBA
09/2011
1Biomarkers (Surrogate Marker)IBA
05/2010
1GasesIBA
11/2003
1Air Pollutants (Pollutants, Air)IBA
11/2003
1OzoneIBA
01/2002
1Carbon MonoxideIBA
01/2002

Therapy/Procedure

10Therapeutics
08/2022 - 10/2002
8Highly Active Antiretroviral Therapy (HAART)
12/2011 - 04/2003
1Radiotherapy
08/2022
1Adjuvant Radiotherapy
08/2022
1Hysterectomy
08/2022
1Organ Transplantation
01/2021
1Treatment Delay
11/2020
1First Aid (Aids, First)
10/2002